HF
VNDA icon

HRT Financial’s Vanda Pharmaceuticals VNDA Stock Holding History

HRT Financial’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$433K Buy
+62,787
New +$484K ﹤0.01% 2637
2025
Q4 		– Sell
-11,280
Closed -$56K – 4119
2025
Q3 		$56K Buy
+11,280
New +$52.2K ﹤0.01% 2593
2024
Q2 		– Sell
-30,658
Closed -$126K – 3176
2024
Q1 		$126K Sell
30,658
-31,264
-50% -$125K ﹤0.01% 1838
2023
Q4 		$261K Sell
61,922
-221,882
-78% -$895K ﹤0.01% 1679
2023
Q3 		$1.23M Buy
+283,804
New +$1.58M 0.01% 863
2023
Q1 		– Sell
-53,627
Closed -$396K – 3255
2022
Q4 		$396K Sell
53,627
-76,158
-59% -$742K 0.01% 1573
2022
Q3 		$1.28M Buy
129,785
+71,692
+123% +$757K 0.01% 782
2022
Q2 		$633K Buy
+58,093
New +$602K 0.01% 1321
2022
Q1 		– Sell
-24,450
Closed -$383K – 3935
2021
Q4 		$383K Buy
+24,450
New +$426K ﹤0.01% 2103
2021
Q3 		– Sell
-17,571
Closed -$377K – 3798
2021
Q2 		$377K Sell
17,571
-12,655
-42% -$226K ﹤0.01% 1997
2021
Q1 		$453K Buy
+30,226
New +$489K ﹤0.01% 1863
2020
Q4 		– Sell
-11,279
Closed -$108K – 2516
2020
Q3 		$108K Sell
11,279
-17,003
-60% -$182K ﹤0.01% 1509
2020
Q2 		$323K Buy
+28,282
New +$320K 0.01% 958
2020
Q1 		– Sell
-15,174
Closed -$249K – 1396
2019
Q4 		$249K Buy
+15,174
New +$229K 0.01% 839
2015
Q3 		– Sell
-10,477
Closed -$132K – 187
2015
Q2 		$132K Buy
+10,477
New +$113K 0.06% 144

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's VNDA Position: Q1 2026 in Review

HRT Financial opened a new position in Vanda Pharmaceuticals (VNDA) in Q1 2026: 62,787 shares worth $433K. The stake represents ﹤0.01% of the portfolio and ranks #2637 among its holdings. This is a return to the name: HRT Financial previously reported a position in VNDA as recently as Q3 2025.

HRT Financial first reported a position in VNDA in Q2 2015 and has held it in 15 quarters since. The position peaked at $1.28M in Q3 2022. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • HRT Financial held 62,787 shares of Vanda Pharmaceuticals worth $433K as of Q1 2026.
  • Vanda Pharmaceuticals was a new HRT Financial position in Q1 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2637 holding.
  • HRT Financial first reported a position in Vanda Pharmaceuticals in Q2 2015 and has held it in 15 quarters since.
  • HRT Financial's Vanda Pharmaceuticals position peaked at $1.28M in Q3 2022.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.